BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37695905)

  • 21. Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma.
    Park S; Shim JH; Lee B; Cho I; Park WY; Kim Y; Lee SH; Choi Y; Han J; Ahn JS; Ahn MJ; Park K; Sun JM
    Lung Cancer; 2019 Aug; 134():7-15. PubMed ID: 31319998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes.
    VanderLaan PA; Rangachari D; Mockus SM; Spotlow V; Reddi HV; Malcolm J; Huberman MS; Joseph LJ; Kobayashi SS; Costa DB
    Lung Cancer; 2017 Apr; 106():17-21. PubMed ID: 28285689
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Kitajima S; Barbie DA
    Clin Cancer Res; 2018 Mar; 24(6):1243-1245. PubMed ID: 29343556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative
    Li C; Lin WY; Rizvi H; Cai H; McFarland CD; Rogers ZN; Yousefi M; Winters IP; Rudin CM; Petrov DA; Winslow MM
    Cancer Res; 2021 Sep; 81(17):4570-4580. PubMed ID: 34215621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic Alteration During Metastasis of Lung Adenocarcinoma.
    Tan Q; Cui J; Huang J; Ding Z; Lin H; Niu X; Li Z; Wang G; Luo Q; Lu S
    Cell Physiol Biochem; 2016; 38(2):469-86. PubMed ID: 26828653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-type specific tumorigenesis with Ras oncogenes in human lung epithelial cells.
    Kumazaki M; Shimomura I; Kiyono T; Ochiya T; Yamamoto Y
    Biochem Biophys Res Commun; 2020 Apr; 525(2):483-490. PubMed ID: 32111352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biology of colorectal cancer.
    Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
    Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.
    Murray CW; Brady JJ; Tsai MK; Li C; Winters IP; Tang R; Andrejka L; Ma RK; Kunder CA; Chu P; Winslow MM
    Cancer Discov; 2019 Nov; 9(11):1590-1605. PubMed ID: 31350327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers.
    Jang JS; Lee A; Li J; Liyanage H; Yang Y; Guo L; Asmann YW; Li PW; Erickson-Johnson M; Sakai Y; Sun Z; Jeon HS; Hwang H; Bungum AO; Edell ES; Simon VA; Kopp KJ; Eckloff B; Oliveira AM; Wieben E; Aubry MC; Yi E; Wigle D; Diasio RB; Yang P; Jen J
    Sci Rep; 2015 May; 5():9755. PubMed ID: 25985019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
    Maity TK; Venugopalan A; Linnoila I; Cultraro CM; Giannakou A; Nemati R; Zhang X; Webster JD; Ritt D; Ghosal S; Hoschuetzky H; Simpson RM; Biswas R; Politi K; Morrison DK; Varmus HE; Guha U
    Cancer Discov; 2015 May; 5(5):534-49. PubMed ID: 25735773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular events in lung cancer.
    Roth JA
    Lung Cancer; 1995 Jun; 12 Suppl 2():S3-15. PubMed ID: 7551947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.
    Okada T; Sinha S; Esposito I; Schiavon G; López-Lago MA; Su W; Pratilas CA; Abele C; Hernandez JM; Ohara M; Okada M; Viale A; Heguy A; Socci ND; Sapino A; Seshan VE; Long S; Inghirami G; Rosen N; Giancotti FG
    Nat Cell Biol; 2015 Jan; 17(1):81-94. PubMed ID: 25531777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
    PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis.
    Lahtela J; Pradhan B; Närhi K; Hemmes A; Särkioja M; Kovanen PE; Brown A; Verschuren EW
    Dis Model Mech; 2015 Apr; 8(4):393-401. PubMed ID: 25713296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive molecular profiling of lung adenocarcinoma.
    Cancer Genome Atlas Research Network
    Nature; 2014 Jul; 511(7511):543-50. PubMed ID: 25079552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulated lncRNA expression profile in the mouse lung adenocarcinomas with KRAS-G12D mutation and P53 knockout.
    Zhang M; Jiang N; Cui R; Du S; Ou H; Chen T; Ge R; Ma D; Zhang J
    J Cell Mol Med; 2019 Oct; 23(10):6978-6988. PubMed ID: 31410985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis.
    Zhao Y; Pan Y; Cheng C; Zheng D; Zhang Y; Gao Z; Fu F; Li H; Zheng S; Zhuge L; Mao H; Kuang M; Tao X; Peng Y; Hu H; Xiang J; Li Y; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1781-1789. PubMed ID: 32361787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy.
    Xu C; Buczkowski KA; Zhang Y; Asahina H; Beauchamp EM; Terai H; Li YY; Meyerson M; Wong KK; Hammerman PS
    Mol Cancer Ther; 2015 Oct; 14(10):2382-2389. PubMed ID: 26206333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic landscape of lung adenocarcinoma in East Asians.
    Chen J; Yang H; Teo ASM; Amer LB; Sherbaf FG; Tan CQ; Alvarez JJS; Lu B; Lim JQ; Takano A; Nahar R; Lee YY; Phua CZJ; Chua KP; Suteja L; Chen PJ; Chang MM; Koh TPT; Ong BH; Anantham D; Hsu AAL; Gogna A; Too CW; Aung ZW; Lee YF; Wang L; Lim TKH; Wilm A; Choi PS; Ng PY; Toh CK; Lim WT; Ma S; Lim B; Liu J; Tam WL; Skanderup AJ; Yeong JPS; Tan EH; Creasy CL; Tan DSW; Hillmer AM; Zhai W
    Nat Genet; 2020 Feb; 52(2):177-186. PubMed ID: 32015526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinoma.
    Takamochi K; Hara K; Hayashi T; Kohsaka S; Takahashi F; Suehara Y; Suzuki K
    Lung Cancer; 2021 Nov; 161():163-170. PubMed ID: 34600407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.